Huge Seller Price Slash to Hit Nexium/Takecab; Rituxan, 8 Other Brands to Face Market Expansion Re-Pricing

Chuikyo General Assembly Meeting on Jan. 17 AstraZeneca’s acid reflux drug Nexium (esomeprazole) and its rival Takecab (vonoprazan) by Takeda Pharmaceutical will be slapped with a price slash of up to 25% in Japan in April 2018 as a key...read more